Advancing Vaccines
For Better Lives
Welcome to Valneva
We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We have leveraged our expertise and capabilities both to commercialize three vaccines, including the world’s first and only chikungunya vaccine, and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease and Zika.
Check out our 2023 Annual Business Report
Follow Us
#climatechange and disease, what's the connection? In a guest post from @valnevaSE Dr Juan Carlos Jaramillo we learn about the growing threat and how we can address it.
#vaccinenation #vaccine #vaccines #disease #infectiousdisease #globalhealth #valneva
https://vaccinenation.org/infection/an-emerging-global-health-threat-climate-changes-impact-on-infectious-diseases/
Today's the last day of #WVCDC. It's been inspiring to share and learn more about some incredible strides in vaccine #innovation.
The Valneva team are still here at booth 433 – stop by for more on our mission and initiatives.
#Vaccines #WVCUSA @vaccinenation